Research Operations
Above & Beyond: Better Utilize In-House Reporting Resources with Advarra Insights
Does your organization utilize your in-house reporting teams and systems to their full potential? Learn how a standardized business intelligence system could complement your current reporting structure to improve your organization’s operations.
4 Reasons Your Institution Needs an eRegulatory System
Using physical binders or an internal shared drive can slow research operations. Implementing an eRegulatory system helps institutions streamline research by transforming key workflows.
How Sites Can Win in the New Age of Genetically Engineered Treatments
The accelerating gene therapy market is expected to grow 16.6 percent by 2027. As gene therapies enter the pipeline, how can sites prepare themselves to take advantage of the rush?
The Power of Getting Everyone in Your Clinical Trial to Work as One Team
Everyone wins when all the stakeholders of a trial work together as a team. Yet, providing this sense of camaraderie across the study ecosystem is difficult.
How Staff Augmentation Assists with Successful Data Migration
With the goal to move active data from one system into OnCore CTMS, Advarra’s Staff Augmentation team worked with a customer’s associated hospital as it was faced with software termination.
UChicago Comprehensive Cancer Center Adopts Industry-Leading Research Administration Technology
The Study Manager’s Guide to Cultivating Positive Site and Patient Relationships
We ask a lot of questions about what makes trials work. From speaking to clinical study sites, investigators, trial patients, and study managers, there is always a common theme: the importance of working as a team.
Biosafety, Ethical, and Logistical Challenges to Pursuing a Coronavirus Vaccine at Warp Speed
The SARS-CoV-2 pandemic has impacted all aspects of society. Various government and private groups around the world are endeavoring to develop safe and effective vaccines at an unprecedented pace and scale to quell the pandemic as quickly as possible.